Very True and Good Reference.
I think a lot have thought their intent was to have produce on shelf and revenue coming in. At best they had hoped in Q4 a minimal amount of revenue.
The first one was done as committed.. with the patent we see the other application study just concluded.
The second I would say is complete/underway as well based on what we know have heard from the company.
The third... though not formally said both fibromyalgia and migraines have been mentioned multiple times and I am inclined to believe that they are pursuing both until which time they have a reason not to. Regarding the advertising in the US... I think that was the CannaNet PR campaign in June/July that got put on hold (which we still have the remainder of the campaign paid for)... why? It is my belief that Big Name Pharma came in and OWCP and whomever went into an NDA. I believe there were talks in June which OWCP leadership held off on doing and then when it looked like it might break down they released the first video and the deal came back on the table and an NDA was signed at that time.
JMO but that's what I believe. One thing that was verbally stated by the company leadership back in Q1 this year was that they were interested in listing to the NASDAQ and an aggressive goal of end of Q4 was mentioned but likely Q1 2018.
I think they are on track for what they have committed though they might not have or for that matter been legally allowed to give us some of the updates we have hoped for.
Remember these guys are paid in shares... They don't want 30 cents a share... they want 30 dollars a share and with their combined knowledge and proven track record I'm inclined they will get it and much more while delivering the same for those who have walked with them through the process.